Watchlist Price Alert

Pieris Pharmaceuticals In... (PIRS)

NASDAQ: PIRS · Real-Time Price · USD

13.60

-2.51 (-15.58%)

At close: Dec 13, 2024, 9:00 PM

Pieris Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-24.54M	-33.28M	-45.74M	-37.23M	-25.47M	-26.75M	-17.65M	-22.8M
Depreciation & Amortization	1.78M	2.78M	2.37M	2.13M	1.04M	570K	369K	361.38K
Stock-Based Compensation	3.35M	4.4M	5.21M	5.09M	5.37M	4.94M	3.05M	1.91M
Other Working Capital	-11.9M	-26.54M	19.55M	-14.5M	-28.52M	8.62M	74.38M	3.75M
Other Non-Cash Items	-22.5M	-467K	-30K	330K	-69K	-1.55M	293K	1.91M
Deferred Income Tax	-4.52M	n/a	n/a	164K	-1.22M	-164K	156K	-1.86M
Change in Working Capital	-7.38M	-33.37M	30.52M	-16.38M	-32.12M	21.89M	63.54M	6.1M
Operating Cash Flow	-53.82M	-59.93M	-7.66M	-45.9M	-52.47M	-1.07M	49.75M	-14.39M
Capital Expenditures	-171K	-1.04M	-949K	-2.73M	-2.46M	-1.7M	-1.95M	-580.64K
Cash Acquisitions	-12.17M	20.2M	n/a	-41.94M	-12.3M	n/a	n/a	20.97K
Purchase of Investments	-22.84M	-48.4M	n/a	-41.5M	-59.32M	-117.58M	-43.92M	n/a
Sales Maturities Of Investments	35.01M	28.2M	n/a	83.44M	71.62M	110.41M	n/a	n/a
Other Investing Acitivies	12.17M	-20.2M	n/a	41.94M	12.3M	-7.18M	-43.92M	20.97K
Investing Cash Flow	12M	-21.24M	-949K	39.21M	9.84M	-8.88M	-45.88M	-559.67K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	19.8M	292K	2.03M	491K	1.17M	1.3M	4.09M	n/a
Financial Cash Flow	19.8M	7.21M	59.13M	10.12M	32.17M	48.51M	4.09M	15.22M
Net Cash Flow	-21.24M	-79.13M	47.33M	8.18M	-12.61M	36.99M	8.52M	6.4K
Free Cash Flow	-53.99M	-60.97M	-8.61M	-48.62M	-54.93M	-2.76M	47.8M	-14.97M